Key result
CRISPR-Cas technology is advancing as a therapeutic tool to combat viral infections by breaking viral DNA and halting replication.
This review summarizes advancements in using CRISPR-Cas technology as a therapeutic tool against viral infections.
Structure:* "[Verdict clause]; [confirms / challenges / extends / leaves open] ...
The clustered regularly interspaced palindromic repeats (CRISPR)/Cas systems have rapidly transitioned from intriguing prokaryotic defense systems to an efficient therapeutic tool. This cutting-edge technology is currently revolutionizing to combat hostile viruses because of its reproducibility, high potency, ease of use, limited off-target activity, and development of quick immune response against viruses. CRISPR gene editing technology eliminates the virus by breaking the DNA that ultimately halts viral replication. This review summarizes the advancements that have been made in the use of CRISPR-Cas technology in viral therapeutics.
No takes yet. Share an insight, caveat, or question.
Wahid et al. (2017) conducted a review in Viral infections. CRISPR-Cas systems was evaluated. CRISPR-Cas technology is advancing as a therapeutic tool to combat viral infections by breaking viral DNA and halting replication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: